Log in

NASDAQ:KIDS - Orthopediatrics Stock Price, Forecast & News

$47.80
+0.11 (+0.23 %)
(As of 01/19/2020 04:00 PM ET)
Today's Range
$46.88
Now: $47.80
$48.04
50-Day Range
$38.01
MA: $44.08
$48.80
52-Week Range
$28.19
Now: $47.80
$51.48
Volume95,266 shs
Average Volume96,866 shs
Market Capitalization$799.22 million
P/E RatioN/A
Dividend YieldN/A
Beta0.28
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$57.56 million
Book Value$6.38 per share

Profitability

Net Income$-12,020,000.00

Miscellaneous

Employees80
Market Cap$799.22 million
Next Earnings Date3/4/2020 (Estimated)
OptionableNot Optionable

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.


Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) announced its quarterly earnings data on Thursday, November, 7th. The company reported ($0.18) earnings per share for the quarter, missing analysts' consensus estimates of ($0.17) by $0.01. The business earned $20.74 million during the quarter, compared to analyst estimates of $19.87 million. Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.12%. The company's revenue for the quarter was up 31.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.15) EPS. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Orthopediatrics.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $19-19 million, compared to the consensus revenue estimate of $18.24 million.

What price target have analysts set for KIDS?

5 equities research analysts have issued 12 month price targets for Orthopediatrics' shares. Their forecasts range from $44.00 to $54.00. On average, they anticipate Orthopediatrics' stock price to reach $49.00 in the next year. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Orthopediatrics.

What is the consensus analysts' recommendation for Orthopediatrics?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

Has Orthopediatrics been receiving favorable news coverage?

Media coverage about KIDS stock has trended positive this week, InfoTrie reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Orthopediatrics earned a news impact score of 3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Orthopediatrics.

Are investors shorting Orthopediatrics?

Orthopediatrics saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 947,000 shares, a decrease of 11.5% from the November 28th total of 1,070,000 shares. Based on an average daily volume of 76,400 shares, the days-to-cover ratio is presently 12.4 days. Currently, 9.7% of the company's stock are sold short. View Orthopediatrics' Current Options Chain.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include Freeport-McMoRan (FCX), Akorn (AKRX), Advanced Micro Devices (AMD), Intel (INTC), AbbVie (ABBV), Boeing (BA), Honeywell International (HON), Nike (NKE), New Residential Investment (NRZ) and ArQule (ARQL).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (4.48%) and Brasada Capital Management LP (0.06%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Kevin Unger and Mark C Throdahl. View Institutional Ownership Trends for Orthopediatrics.

Which institutional investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Brasada Capital Management LP. Company insiders that have sold Orthopediatrics company stock in the last year include David R Bailey and Mark C Throdahl. View Insider Buying and Selling for Orthopediatrics.

Which institutional investors are buying Orthopediatrics stock?

KIDS stock was purchased by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC. View Insider Buying and Selling for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $47.80.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $799.22 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.View Additional Information About Orthopediatrics.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is http://www.orthopediatrics.com/.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  242 (Vote Outperform)
Underperform Votes:  240 (Vote Underperform)
Total Votes:  482
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel